← Back to catalogue

TheraSeed®, SourceCap™

FDA UDI

Class II (US FDA UDI)

by Bard Brachytherapy, Inc

Identity

Trade Name
TheraSeed®, SourceCap™ FDA UDI
Generic Name
Brachytherapy source spacer FDA UDI
Device Name
Model 200 TheraSeed® Palladium-103 Preloaded in Needles with SourceCap™ Endcaps FDA UDI
Model / Reference
200PAPF FDA UDI
Description
Model 200 TheraSeed® Palladium-103 Preloaded in Needles with SourceCap™ Endcaps FDA UDI

Identifiers

Catalog Number
200PAPF FDA UDI
Primary DI / UDI-DI
00801741098666 FDA UDI
510(k) Number
K060636 FDA UDI
FDA Product Code
KXK FDA UDI
GMDN Term
Brachytherapy source spacer FDA UDI

Classification

Device Class
Class II FDA UDI
Regulation Number
892.5730 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

Yes

FDA UDI

Single Use

Yes

FDA UDI

Implantable

Yes

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

Yes

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

No

FDA UDI

Serial Number

Yes

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Category: Brachytherapy injection needleManual brachytherapy source, permanent implantBrachytherapy source spacer

TheraSeed®, SourceCap™ by Bard Brachytherapy, Inc — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Brachytherapy source spacer.

Cleared under the same submission

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (1)

  • FDA UDI ce8a4cd4-9a35-4036-b442-0336dce41d9a 37 fields · synced May 31, 2026